ADA2
Adenosine deaminase 2
Also known as: ADA2_HUMAN, ADGF, CECR1, IDGFL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZK5
- Gene
- ADA2
- Ensembl
- ENSG00000093072
- Chromosome
- 22
- Canonical length
- 511 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
511 residues, UniProt reviewed canonical sequence.
>Q9NZK5|ADA2
1 MLVDGPSERP ALCFLLLAVA MSFFGSALSI DETRAHLLLK EKMMRLGGRL VLNTKEELAN
61 ERLMTLKIAE MKEAMRTLIF PPSMHFFQAK HLIERSQVFN ILRMMPKGAA LHLHDIGIVT
121 MDWLVRNVTY RPHCHICFTP RGIMQFRFAH PTPRPSEKCS KWILLEDYRK RVQNVTEFDD
181 SLLRNFTLVT QHPEVIYTNQ NVVWSKFETI FFTISGLIHY APVFRDYVFR SMQEFYEDNV
241 LYMEIRARLL PVYELSGEHH DEEWSVKTYQ EVAQKFVETH PEFIGIKIIY SDHRSKDVAV
301 IAESIRMAMG LRIKFPTVVA GFDLVGHEDT GHSLHDYKEA LMIPAKDGVK LPYFFHAGET
361 DWQGTSIDRN ILDALMLNTT RIGHGFALSK HPAVRTYSWK KDIPIEVCPI SNQVLKLVSD
421 LRNHPVATLM ATGHPMVISS DDPAMFGAKG LSYDFYEVFM GIGGMKADLR TLKQLAMNSI
481 KYSTLLESEK NTFMEIWKKR WDKFIADVAT KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- spleen: 106 nTPM
- tonsil: 61 nTPM
- thymus: 53 nTPM
- lung: 53 nTPM
- lymph node: 48 nTPM
- choroid plexus: 47 nTPM
Single-cell type
- kupffer cells: 338 nCPM
- monocytes: 244 nCPM
- cdc: 181 nCPM
- macrophages: 143 nCPM
- rod photoreceptor cells: 125 nCPM
- monocyte progenitors: 124 nCPM
Immune cell
- classical monocyte: 219 nTPM
- intermediate monocyte: 214 nTPM
- non-classical monocyte: 183 nTPM
- total PBMC: 173 nTPM
- myeloid DC: 143 nTPM
- plasmacytoid DC: 62 nTPM
Brain region
- white matter: 41 nTPM
- choroid plexus: 37 nTPM
- medulla oblongata: 31 nTPM
- pons: 24 nTPM
- spinal cord: 24 nTPM
- hypothalamus: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADA2.
Disease | AllUniProt
Conditions ADA2 is implicated in, by any mechanism.
- Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS) MIM:615688
- Sneddon syndrome (SNDNS) MIM:182410
Disease | GeneticClinVar
91 pathogenic / likely-pathogenic of 613 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of adenosine deaminase 2
- Sneddon syndrome
- ADA2-related disorder
- Autoinflammatory syndrome
- Inherited Immunodeficiency Diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- adenosine deaminase activity
- adenosine receptor binding
- growth factor activity
- heparin binding
- protein homodimerization activity
- proteoglycan binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Adenosine deaminase domain
- Adenosine/adenine deaminase
- Metal-dependent hydrolase
- Adenosine deaminase
- Adenosine deaminase-related growth factor
- Adenosine/AMP deaminase N-terminal
- Adenosine/AMP deaminase N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADA2 as an antibody target. Whether an autoantibody or antibody against ADA2 could matter depends on whether native ADA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADA2 is annotated as secreted, so native ADA2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...